Baumhackl, U <br/><br/>
A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Apr 2005 
 - 166-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1191/1352458505ms1132oa  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Bromelains--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Magnetic Resonance Imaging<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Placebos<br/>Recurrence<br/>Rutin--administration & dosage<br/>Treatment Outcome<br/>Trypsin--administration & dosage